Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Other financing activities (2016 - 2021)

Historic Other financing activities for Medifast (MED) over the last 12 years, with Q3 2021 value amounting to $34000.0.

  • Medifast's Other financing activities fell 555.56% to $34000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $1.9 million, marking a year-over-year increase of 23380.53%. This contributed to the annual value of $551000.0 for FY2020, which is 9609.0% down from last year.
  • Latest data reveals that Medifast reported Other financing activities of $34000.0 as of Q3 2021, which was down 555.56% from $26000.0 recorded in Q2 2021.
  • Medifast's 5-year Other financing activities high stood at $2.2 million for Q4 2017, and its period low was $9000.0 during Q2 2020.
  • Moreover, its 5-year median value for Other financing activities was $35000.0 (2018), whereas its average is $372937.5.
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 7846.36% in 2018, then surged by 27104.72% in 2021.
  • Quarter analysis of 5 years shows Medifast's Other financing activities stood at $2.2 million in 2017, then plummeted by 78.46% to $471000.0 in 2018, then tumbled by 92.99% to $33000.0 in 2019, then plummeted by 42.42% to $19000.0 in 2020, then surged by 78.95% to $34000.0 in 2021.
  • Its last three reported values are $34000.0 in Q3 2021, $26000.0 for Q2 2021, and $1.8 million during Q1 2021.